Drug Profile
Research programme: central nervous system disorder therapeutics - Hua Medicine
Alternative Names: mGLUR5 NAM - Hua medicine; mGLUR5-NAM - Hua MedicineLatest Information Update: 18 Oct 2022
Price :
$50
*
At a glance
- Originator Hua Medicine
- Class Antiparkinsonians; Neuroprotectants; Small molecules
- Mechanism of Action Metabotropic glutamate receptor 5 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Depressive disorders; Fragile X syndrome; Parkinson's disease
Most Recent Events
- 18 Oct 2022 Preclinical development is ongoing in China (Hua Medicine pipeline, October 2022)
- 28 Apr 2020 No recent reports of development identified for preclinical development in Depressive disorders in China
- 28 Apr 2020 No recent reports of development identified for preclinical development in Fragile-X-syndrome in China